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Abstract
Introduction. Matrix metalloproteinase enzymes (MMPs) play important role in inflammation, malignant cell prolif-
eration, invasion and angiogenesis by mediating extracellular matrix degradation. Doxycycline, a synthetic tetracycline, 
behaves as a MMP inhibitor at a subantimicrobial dose and inhibits tumor cell proliferation, invasion and angiogenesis. 
The aberrant activity of nuclear factor kappa B (NF-kB) causes activation of MMPs and thereby proliferation and 
invasion of cancer cells. The aim of this study was to investigate the effects of doxycycline on the expression of MMPs 
in lipopolysaccharide (LPS)-induced PC3 human prostate cancer cells and the possible role of NF-kB signaling. 
Material and methods. PC3 cells were incubated with LPS (0.5 µg/mL) for 24 h in the presence or absence of doxy-
cycline (5 µg/mL). The effects of LPS and doxycycline on the expressions of MMP-2, MMP-8, MMP-9, MMP-10, 
NF-kB/p65, IkB-a, p-IkB-a, IKK-b were examined by Western blotting and immunohistochemistry in PC3 cells. 
Furthermore, relative proteinase activities of MMP-2 and MMP-9 were determined by gelatin zymography.
Results. LPS increased expression and activity of MMP-9 and expression of MMP-8, MMP-10, NF-kB/p65, 
p-IkB-a, IKK-b and doxycycline down-regulated its effects with the exception of MMP-10 expression. The ex-
pression of MMP-2 and IkB-a was affected by neither LPS nor doxycycline. 
Conclusions. Our findings indicate that doxycycline inhibits the expression of various MMPs and NF-kB signaling 
may play a role in the regulation of MMPs expression in LPS-induced PC3 human prostate cancer cells. (Folia 
Histochemica et Cytobiologica 2016, Vol. 54, No. 4, 171–180)
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Introduction
Prostate cancer is the third cause of cancer-associated 
death in men after lung cancer in developed countries 
[1–3]. Although early detection of prostate cancer is 
crucial, several biomarkers for early screening are still 
controversial [4, 5]. Over 70% of the patients are cured 
after various primary treatment options such as surgery, 
radiotherapy and androgen-deprivation therapy [2, 6]. 
However, recurrence which occurs in 34% of the pa-
tients within 5 years and in 46% of the patients after 
10 years limits management of the disease and prevents 
better cancer control and lower morbidity [2, 6]. There-
fore, understanding the underlying mechanism of the 
disease may be critical in the development of novel 
approaches for appropriate diagnosis and treatment. 
Matrix metalloproteinases (MMPs) are a family 
of zinc-dependent endopeptidases which degrade 
extracellular matrix (ECM) components and play an 
essential role in the processes of cancerogenesis in-
cluding tumor growth, angiogenesis, invasion and me-
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tastasis [7, 8]. MMPs were divided into subgroups of 
collagenases (MMPs-1, -8, -13), gelatinases (MMPs-2, -9), 
stromelysins (MMPs-3, -10, -11), membrane-type 
MMPs (MMPs-14 to -17), and other MMPs (e.g., 
MMP-12) [9]. Activity of MMPs is tightly regulated by 
endogenous tissue inhibitors of MMPs (TIMPs) [9]. 
In numerous clinical and experimental studies related 
to various types of cancers, overexpression of MMPs, 
in particular MMP-2 and MMP-9 (gelatinases) and 
low levels of TIMPs were reported [7, 10, 11]. Ac-
cordingly, targeting MMPs may be an efficient thera-
peutic strategy to control tumorigenesis, invasion and 
metastasis [12].
Tetracyclines at the subantimicrobial dose inhibit 
MMPs by the mechanism independent from their 
antimicrobial activity [13]. They inhibit MMPs via 
chelating the catalytic Zn+2 ion in the active site of 
MMP molecule [14].
Tetracyclines have high affinity to bone tissue which 
serves as a drug reservoir. They also inhibit metastasis 
of cancer cells to the bone and protect connective tissue 
from excessive breakdown mediated by MMPs [2, 15, 
16]. Doxycycline at subantimicrobial dose is the unique 
MMP inhibitor which was approved by Food and 
Drug Administration for the treatment of periodontal 
diseases [17, 18]. However, molecular mechanisms 
responsible for the inhibitory effect of doxycycline on 
MMPs have yet not been fully understood.
Nuclear Factor Kappa B (NF-kB) belongs to 
a family of transcription factors which provide a pivotal 
link between inflammation and cancer [19, 20]. NF-kB 
activity is regulated by two main pathways which are 
known as the classical (canonical) pathway and the al-
ternative one. The classical pathway plays a crucial role 
in the control of inflammation. In this pathway, Rel A 
(p65)-p50 dimer which consists of two members of NF- 
-kB family exists in an inactive form bound to inhibitory 
IkB-a (inhibitor of kappa B-a) molecule. Phosphoryla-
tion of the IKK (IkB kinase) complex that consists of 
IKKa, IKKb, and IKKg, leads to the phosphorylation 
of inhibitory IkB-a molecule and to the release of Rel 
A (p65)-p50 from Rel A (p65)-p50-IkB-a complex. 
Then, IkB-a is marked for degradation by the prote-
asome pathway and Rel A (p65)-p50 translocates to 
cell nucleus. In nucleus, Rel A (p65)-p50 binds to the 
promoter region of target genes and induces expres-
sion of NF-kB-related genes. For the termination of 
NF-kB signaling, cytoplasmic synthesis of new IkB-a is 
necessary. The new IkB-a enters the nucleus and binds 
to the Rel A (p65)-p50. This causes the dissociation 
of Rel A (p65)-p50-IkB-a complex from DNA and its 
re-exportation to the cytoplasm [21–23]. 
Increased activation of NF-kB signaling through 
proinflammatory stimuli in tumor microenvironment 
has been demonstrated to stimulate proliferation, 
migration and metastasis of cancer cells and inhibit 
apoptosis in many human malignancies including 
prostate cancer [20, 23, 24]. More importantly, in 
breast cancer patients NF-kB activation promoted 
up-regulation of MMP-9 which was closely associated 
with shorter lifespan [25]. All of the studies related 
to the NF-kB-dependent-MMP regulation in pros-
tate cancer focused on the regulation of gelatinases 
(MMP-2 and -9) [23, 26]. However, the role of NF-kB 
activation in the gene regulation of MMPs from the 
subgroups of collagenases and stromelysins in prostate 
cancer has not been studied yet. Additionally, the 
modulating effects of lipopolysaccharide (LPS) which 
is an inflammatory stimulus on NF-kB translocation 
and regulation of MMPs in prostate cancer remains 
to be investigated.
On the other hand, various anticancer agents were 
reported to inhibit NF-kB signaling-mediated MMP 
up-regulation in prostate cancer [27, 28]. Similarly, 
doxycycline was shown to suppress NF-kB signaling in 
LPS-treated microglial cells [29]. However, the effects 
of doxycycline on NF-kB signaling and regulation of 
MMP expression in prostate cancer have yet not been 
examined. 
Hence, in the current study, we investigated the 
effects of doxycycline at subantimicrobial dose on the 
regulation of the expression of MMPs from diverse 
subgroups including gelatinases, collagenases and 
stromelysins, and a possible contribution of NF-kB 
signaling to this expression in LPS-induced PC3 hu-
man prostate cancer cells.
Material and methods
Reagents. Cell culture media (RPMI 1640), fetal bovine 
serum (FBS) and L-glutamine were obtained from Gibco, 
Thermo Fisher Scientific, Gran Island, NY, USA. Electro-
phoresis reagents and LPS (Lipopolysaccharides isolated 
from E. coli 026:B6, L2654) were purchased from Sig-
ma-Aldrich, St. Louis, MO, USA. The chemiluminescence 
visualization reagent ImmunoCruz was from SantaCruz 
Biotechnology Inc., Santa Cruz, CA, USA. The molecular 
weight marker (PageRuler Plus Prestained Protein Ladder) 
was obtained from Thermo Fisher Scientific. Doxycycline 
hyclate (PubChem CID:54732805) was purchased from 
Kaifeng Pharmaceutical Group Co., Ltd. Kaifeng, Henan, 
China. Primary antibodies were detailed in Table S.1. 
Doxycycline and LPS solutions were freshly prepared each 
time by dissolving in sterile water and then sterilized using 
a syringe filter (Minisart, Goettingen, Germany).
 
Cell culture. PC3 cell line was a kind gift from Dr. K.S. 
Korkmaz, Ege University, Izmir, Turkey (the cell line was 
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obtained from American Type Culture Collection; ATCC). 
The cells were routinely maintained in RPMI 1640 medium 
supplemented with 10% FBS, 1% penicillin/streptomycin 
(5 mg/mL) and 1% L-glutamine (200 mM) in a humidified 
atmosphere containing 5% CO2 at 37°C.
 
Induction and treatment of the cells. Cells were seeded into 
12-well plates. When they became confluent, they were in-
duced with 0.5 µg/mL LPS [30, 31] in the presence or absence 
of 5 µg/mL doxycycline [32] for 24 h. The optimal concentra-
tion of LPS and doxycycline were determined in consideration 
of our preliminary studies (data not shown). Uninduced and 
untreated cells were maintained as control cells for the same 
period of time. In all experiments doxycycline and LPS were 
added into the culture media at the same time. Cells were 
collected and stored at –80°C for further investigations.
 
Cell lysis and protein extraction. Cells were resuspended 
in 250 µL of lysis buffer (20 mM HEPES pH = 7.4, 0.1% 
Triton X-100, 0.2 mM EDTA, 300 mM NaCl) then collected 
from culture plates and transferred to Eppendorf tubes. The 
tubes were incubated on ice and centrifuged at 13,000 rpm 
for 30 min and then supernatants were collected. Protein 
concentration in lysates was measured fluorometrically by 
using Quant-IT protein assay kit (Invitrogen, Carlsbad, CA, 
USA) according to the manufacturer’s protocol.
Western blotting. Under standard conditions, 25 µg of pro-
tein from each cell extract was loaded to 10% SDS-PAGE 
gels and separated by BioRad vertical electrophoresis 
system (Mini-PROTEAN Tetra Cell, BioRad Cat No:165-
8001, Hempstead, UK). Then, the gels were transferred 
to PVDF membrane (Amersham, Buckinghamshire, UK) 
by semi-dry transfer blotter (VWR, V20-SDB, Tingalpa, 
Australia). PVDF membranes were blocked with block-
ing solution (PBS-T, Phosphate-Buffered Saline solution 
containing 5% dry milk and 0.1% Tween 20) for 1 hour. 
Incubations with primary and secondary antibody were 
carried out using PBS-T containing 5% dry milk at 4oC 
overnight and immunoblotted with primary antibodies. 
Primary antibodies used were rabbit antibodies specific for 
MMP-9, MMP-10, MMP-8, NF-kB/p65, IkB-a, phosphory-
lated IkB-a (p-IkB-a), IKK-b, b-actin and mouse antibody 
specific for MMP-2. Membranes were developed using 
horseradish peroxidase-coupled secondary antibody and 
Western blotting (WB) luminol reagent (ImmunoCruz). 
Western blots were photographed by Fusion FX7 (Vilbert 
Lourmat, Collégien, France) and optical densities of blotting 
images were quantified by ImageJ software (ImageJ 1.46r, 
National Institutes of Health, Bethesda, MD, USA) and 
were normalized with b-actin.
Gelatin zymography. Equal protein concentration (25 µg) 
of each zymography sample was loaded into 10% polyacryl-
amide gels containing 2 mg/mL gelatin and were subjected 
to SDS-polyacrylamide gel electrophoresis. Then, SDS was 
removed from the gels and gels were incubated at 37oC for 
48 h in incubation buffer (50 mM Tris-HCl, pH 8.0, 50 mM 
NaCl, 10 mM Ca2Cl, and 0.05% Triton X-100). After the 
incubation period, gels were stained in 0.2% Coomassie 
Brilliant Blue. Images of the gels were photographed by 
using Fusion FX7. Gelatinase activity was detected as clear 
bands on dark backgrounds. Densitometric analysis of the 
bands was performed using ImageJ software. 
Immunohistochemistry. Cell medium and cell suspension 
were added on to coverslips placed in six well plates. The 
cells were kept in a humidified atmosphere containing 5% 
CO2 at 37°C for 24 h to allow cells to adhere to coverslips. 
Then, the adhered cells were incubated with LPS and/or 
doxycycline for the next 24 h in a humidified atmosphere 
containing 5% CO2 at 37°C. Some of the coverslips were kept 
as control cells incubated without LPS and doxycycline. After 
treatment period, cell media were removed and cells were 
fixed in 96% ethanol for 15 min. Then, ethanol was removed, 
cells on the cover slips were rehydrated through alcohol 
series and then washed with distilled water. Following these 
steps, the cells were treated with a solution of 0.125% trypsin 
(diluted with Digest All 2A; 00-3008, Zymed, San Francisco, 
CA, USA) for 5 min at 37°C. Then cells were incubated in 
a solution of 3% H2O2 for 5 min and with normal serum block-
ing solution. Coverslips were first incubated in a humidified 
chamber for 18 h at 4°C with primary antibodies against 
MMP-8, MMP-9, NF-kB/p65, IKK-b, p-IkB-a and thereafter 
with biotinylated IgG, and then with streptavidin conjugat-
ed to horseradish peroxidase according to kit instructions 
(85-9043, Invitrogen). Finally, coverslips were stained with 
DAB (diaminobenzidine, 1718096, Roche, Mannheim, 
Germany) and counter-stained with Mayer’s hematoxylin. 
After that, images of cells were captured by using a BX-51 
light microscope (Olympus, Tokyo, Japan) equipped with 
a high-resolution video camera (Olympus DP-71). The in-
tensity of immunopositivity for each protein was evaluated 
using immunoscoring scale by two histologists, who were 
blinded to the treatment of the samples. The immunoscor-
ing was performed semi-quantitatively, by considering 
the degree of positive cytoplasmic staining of cells and by 
scoring according to the following scale: negative (0), weak 
(1), moderate (2) and strong (3) immunoreactivity. A mean 
score was calculated for each sample. Then, mean scores 
were used to categorize immunopositivity as weak (< 1.5) 
or strong (> 1.5).
Statistical analyses. All data were expressed as mean ± 
S.E.M. Statistical analyses of the data were performed 
using SPSS software for Microsoft Windows (IBM SPSS 
PASW Statistics 19 Fix Pack 1 Amos 19, Chicago, IL, 
USA). The statistical analyses for the data from WB and 
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gelatin zymography were carried out using paired Student’s 
t-test. Chi-square test was performed to evaluate the sta-
tistical difference of immunostaining between the groups. 
P ≤ 0.05 was considered statistically significant.
Results
Effects of LPS and doxycycline on the expression 
and activities of gelatinases
We examined the effects of concomitant LPS (0.5 µg/mL) 
and doxycycline (5 µg/mL) treatment for 24 h on gelatinases 
(MMP-2 and MMP-9) by gelatin zymography and WB ana-
lysis in PC3 cells. In zymogram, we determined barely visible 
bands of lysis representing pro MMP-9 and pro MMP-2 at 
molecular positions of 97 kDa and 72 kDa, respectively, and 
the active MMP-2 at molecular position of 68 kDa (Figure 1). 
Bands of lysis of both pro MMP-9 and pro MMP-2 as well 
as active MMP-2 were too faint for efficient quantitation 
in PC3 cells.
Gelatin zymography analysis demonstrated that incuba-
tion with LPS for 24 h significantly increased active MMP-9 
level in LPS-induced PC3 cells (Figure 1). Doxycycline treat-
ment for 24 h significantly inhibited this effect (Figure 1). 
However, doxycycline treatment for the same period had 
no effect on PC3 cells that were not incubated with LPS 
(Figure 1).
The expression of MMP-9 was also studied by WB 
analysis. Consonantly with our zymography findings, the 
WB results showed that MMP-9 expression was signi-
ficantly up-regulated in LPS-induced cells compared to 
non-induced control cells (Figure 2). However, doxycy-
cline treatment significantly inhibited MMP-9 expression 
in LPS-induced cells (Figure 2). In parallel with the 
data from gelatin zymography analysis, WB results also 
demonstrated that MMP-2 expression was not affected 
by either induction with LPS or doxycycline treatment in 
PC3 cells (Figure 2).
Immunohistochemical analysis of MMP-9  
expression in PC3 cells
To confirm the effects of induction with LPS and 
doxycycline treatment on MMP-9 expression, we 
evaluated the intensity of positive staining of MMP-9 
by conducting immunohistochemical (IHC) staining 
and immunoscoring.
The data showed that LPS caused a significant in-
crease in the intensity rate of positive immunostaining 
of cells with an anti-MMP-9 antibody, but doxycycline 
significantly decreased immunopositivity of MMP-9 
in LPS-induced PC3 cells (Table 1, Figure 3). Doxy-
cycline did not affect MMP-9 expression in control, 
LPS-uninduced PC3 cells (Table 1, Figure 3). These 
results indicate that doxycycline inhibits LPS-induced 
expression and activity of MMP-9 (gelatinase-2) in 
PC3 prostate cancer cells.
Effects of LPS and doxycycline on the expression  
of MMP-8 and MMP-10 
WB findings evidenced that LPS stimulated MMP-8 
expression but doxycycline treatment for 24 h signifi-
cantly down-regulated MMP-8 expression in LPS-in-
duced PC3 cells. Doxycycline treatment for 24 h did 
not change MMP-8 expression level in uninduced 
PC3 cells (Figure 2).
WB showed that LPS significantly up-regulated 
MMP-10 expression, while doxycycline treatment did 
not change MMP-10 expression level in LPS-induced 
PC3 cells (Figure 2).
In addition, we assessed MMP-8 expression 
by performing IHC staining and immunoscoring 
Figure 1. Effects of LPS and doxycycline treatment on gelatinase (MMP-2 and -9) expressions and activities in PC3 cells. 
Gelatinase expressions and activities were determined by gelatin zymography after induction with LPS and doxycycline  
treatment for 24 h and were shown by a representative zymogram. Relative proteinase activity of active MMP-9 was  
expressed as mean ± SEM (n = 7). *P ≤ 0.05, uninduced (LPS–) control PC3 cells versus LPS-induced (LPS+, 0.5 µg/mL)  
control cells; ++P ≤ 0.01, LPS-induced (LPS+) control cells versus LPS-induced (LPS+) and doxycycline (5 µg/mL)  
treated PC3 cells; paired Student’s t-test. Abbreviations: C — control; D — doxycycline; LPS — LPS-induced;  
LPS+D — LPS-induced and doxycycline-treated; aMMP — active MMP; pMMP — proMMP
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for confirmation. In parallel with the WB results, 
IHC analysis revealed that positive cytoplasmic 
staining of cells with an anti-MMP-8 antibody sig-
nificantly increased in LPS-induced cells (Table 1, 
Figure 3). However, intensity of MMP-8 immu-
nostaining significantly declined with doxycycline 
treatment for 24 h in LPS-induced PC3 cells (Table 1, 
Figure 3).
Effects of LPS and doxycycline  
on IKK/IkB/NF-kB axis 
In order to determine the effects of LPS and doxy-
cycline on NF-kB signaling pathway proteins, we 
examined the expressions of NF-kB/p65, IKK-b, 
IkB-a and p-IkB-a in the presence or absence of LPS 
and/or doxycycline by performing WB analysis and 
IHC staining. 
Figure 2. Effects of 0.5 µg/mL LPS and 5 µg/mL doxycycline treatment for 24 h on the expressions of MMP-2, -9, -8 and -10 
in PC3 cells. Expression of MMP-2, -9, -8, -10 on Western blotting after induction with LPS and doxycycline treatment for 
24 h were shown by representative Western blots. Relative expression of MMP-2, -9, -8 and -10 was expressed as mean 
± SEM (n = 5 or 6). *P ≤ 0.05, ***P ≤ 0.001 uninduced (LPS–) control versus LPS-induced (LPS+, 0.5 µg/mL) control; 
+P ≤ 0.05, LPS-induced (LPS+) control versus LPS-induced (LPS+) doxycycline (5 µg/mL) treated PC3 cells, #P ≤ 0.05 
uninduced (LPS–) doxycycline versus LPS-induced (LPS+) doxycycline-treated PC3 cells; paired Student’s t-test.  
Abbreviations as in the description of Figure 1. 
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Figure 3. Representative photomicrographs of the immunohistochemical demonstration of anti-MMP-8, anti-MMP-9, 
anti-NF-kB, anti-IKK-b, anti-IkB-a and anti-p-IbB-a in PC3 cells after induction with LPS and doxycycline treatment for 
24 h. Cells were cultured and stained immunohistochemically as described in Material and methods. Arrows point out 
immunopositive staining, magnification ×40, bar 50 µm. Abbreviations as in the description of Figure 1. 
Table 1. Immunopositivity scores of anti-MMP-8, anti-MMP-9, anti-NF-kB, anti-IKK-b and anti-p-IkB-a staining in PC3 
cells after induction with LPS and treatment with doxycycline for 24 hours
Control PC3  
cells
Doxycycline-treated  
PC3 cells
LPS-induced  
PC3 cells
LPS-induced and doxycycline-treated 
PC3 cells
MMP-8 0.467 ± 0.133 0.400 ± 0.131 2.133 ± 0.165a 1.333 ± 0.126b
MMP-9 0.600 ± 0.131 0.600 ± 0.131 2.533 ± 0.133a 1.467 ± 0.133b
NF-kB 0.400 ± 0.131 0.400 ± 0.131 2.267 ± 0.182a 1.467 ± 0.133b
IKK-b 0.467 ± 0.133 0.467 ± 0.133 2.067 ± 0.118a 1.067 ± 0.067b
p-IkB-a 0.667 ± 0.126 0.533 ± 0.133 2.133 ± 0.165a 1.333 ± 0.126b
PC3 cells were stained immunohistochemically as described in Material and methods. Immunopositivity scores are expressed as mean ± SEM (n = 3).  
aSignificantly different from the respective control value, P £ 0.05, Chi-square test; bSignificantly different from the respective LPS value,  
P £ 0.05, c2 test.
C D LPS LPS+D
MMP-8
MMP-9
NF-kB
IKK-b
p-IkB-a
WB results demonstrated that induction with LPS 
significantly up-regulated NF-kB/p65 expression in 
PC3 cells and doxycycline significantly suppressed this 
effect (Figure 4). Moreover, also IKK-b expression 
was significantly up-regulated by LPS. Although doxy-
cycline tended to down-regulate IKK-b expression 
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Figure 4. Effects of LPS and doxycycline treatment on the expressions of NF-kB/p65, IKK-b, IkB-a and p-IkB-a in PC3 
cells. Expressions of NF-kB/p65, IKK-b, IkB-a and p-IkB-a on Western blot after induction with LPS and doxycycline 
treatment for 24 h were shown by representative Western blots. Relative expression of NF-kB/p65, IKK-b, IkB-a and 
p-IkB-a were expressed as mean ± SEM (n = 4–8). *P ≤ 0.05, **P £ 0.01 uninduced (LPS–) control versus LPS-induced 
(LPS+, 0.5 µg/mL) control; +P £ 0.05, LPS-induced (LPS+) control versus LPS-induced (LPS+) doxycycline (5 µg/mL) 
treated PC3 cells; paired Student’s t-test. Abbreviations as in the description of Figure 1.
level, this effect was not statistically significant in 
LPS-induced PC3 cells (Figure 4). 
WB analyses showed that IkB-a expression was not 
affected by either induction with LPS or doxycycline 
treatment in PC3 cells (Figure 4). WB analyses also 
showed that p-IkB-a expression was significantly 
up-regulated by LPS; however, doxycycline inhibited 
the p-IkB-a up-regulation (Figure 4). 
To corroborate the data from WB experiments, 
we assessed the immunopositive staining scores for 
NF-kB/p65, IKK-b and p-IkB-a. We observed that 
immunopositive staining scores of NF-kB/p65, IKK-b 
and p-IkB-a were significantly higher in LPS-induced 
cells than the scores in uninduced control cells (Ta-
ble 1, Figure 3). 
We also observed more intense immunostaining 
for NF-kB/p65 in the nuclei of LPS-induced cells, 
which is the landmark of increased nuclear transloca-
tion of NF-kB (Figure 3). IHC analyses also revealed 
that doxycycline treatment significantly decreased im-
munopositive staining and immunopositive scores for 
NF-kB/p65, IKK-b and p-IkB-a in LPS-induced PC3 
178 Deniz Ogut et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2016
10.5603/FHC.a2016.0022
www.fhc.viamedica.pl
cells (Table 1, Figure 3). We also observed apparently 
impaired staining in cell nucleus where NF-kB/p65 is 
translocated in LPS-induced doxycycline-treated cells 
compared with LPS-induced control cells (Figure 3). 
Discussion
In this study, we investigated the effects of doxycy-
cline at subantimicrobial dose on the regulation of 
MMPs from diverse subgroups and the contribution 
of NF-kB signaling as a possible underlying mech-
anism in LPS-induced PC3 human prostate cancer 
bone metastasis cells. In this context, we evaluated 
the expression and activity of proteinases repre-
senting different subgroups of MMPs: MMP-2/-9 
(gelatinases), expression of MMP-8 (collagenases) 
and MMP-10 (stromelysins) in the presence or ab-
sence of doxycycline in LPS-induced or uninduced 
PC3 cells. We also have examined in these cells the 
expression levels of the members of the classical 
NF-kB activation pathway including NF-kB/p65, acti-
vator kinase IKK-b, which has a pivotal role in NF-kB 
activation, and inhibitor IkB-a. 
We found that the expression of NF-kB/p65, IKK-b 
and p-IkB-a was significantly up-regulated in parallel 
with the increased expression of MMP-9, -8 and -10 in 
LPS-induced PC3 cells. These results for the first time 
indicate that LPS-induced up-regulation of MMP-8, -9 
and -10 from different subgroups of MMPs may be 
at least partly mediated by the activation of NF-kB 
signaling in PC3 human prostate cancer cells. 
Consistent with our evidence, a recent study re-
ported that LPS-induced TLR4 activation leads to 
NF-kB activation and up-regulation of MMP-2 and -9 
in colorectal cancer cells [33]. Similarly, it was pre-
viously found that metadherin, a newly identified 
oncogene inhibits LPS-induced NF-kB activation 
and downstream MMP-9 regulation in the migration 
and invasion of breast cancer cells [34]. In line with 
these reports, UDN glycoprotein isolated from Ulmus 
davidiana Nakai was demonstrated in LPS-induced 
colon cancer epithelial cell line HCT-116, to block 
activities of NF-kB and activator protein-1 (AP-1) 
and had inhibitory effect on MMP-9 activation [35]. 
Moreover, it was reported that LPS stimulated NF-kB 
activation and promoted the invasiveness of pancreatic 
cancer cells by increasing MMP-9 mRNA expres - 
sion [36]. Interestingly, in all these studies, MMP-9 was 
implicated in LPS-induced NF-kB activation-mediated 
downstream MMP gene regulation in diverse cancer 
cell types. However, the effect of LPS on NF-kB acti-
vation and related MMP regulation in prostate cancer 
have not been elucidated yet. In this respect, our novel 
findings show that LPS, a well-known TLR4 ligand, 
may affect NF-kB signaling and downstream MMP 
gene regulation in PC3 prostate cancer cells. 
In a limited number of studies, the role of MMP-8 
and -10 were examined in prostate cancer cell prolif-
eration, migration and invasion [37, 38]. Nevertheless, 
previous studies have not addressed the relationship 
between NF-kB signaling and downstream gene reg-
ulation of MMP-8 and-10 in prostate cancer. For the 
first time, our study suggests that LPS-induced NF-kB 
activation may contribute to the regulation of differ-
ent classes of MMPs in PC3 prostate cancer cells.
Our study is the first to indicate inhibitory effect 
of doxycycline on the expression of MMPs in LPS-in-
duced PC3 human prostate cancer cells. Recent stud-
ies also showed that doxycycline inhibited activity of 
gelatinases and diminished tumor growth, invasion 
and metastasis in osteosarcoma, and lung, ovarian, 
cervical and oral cancer cell lines [39–42]. Similarly, 
zoledronate, which is nitrogen-containing bisphos-
phonate, exerts antitumoral effects by suppressing 
MMP expression and/or activity in various cancers 
[43, 44]. Recently, we have also reported that zole-
dronate downregulated MMP-2 and -9 expression and 
activities in PC3 prostate cancer cells [45]. Although 
LPS caused the up-regulation of MMP-10 expression, 
doxycycline had no effect on MMP-10 expression in 
PC3 cells. In this respect, further studies may help 
to clarify the basis for the lack of inhibitory effect 
of doxycycline on MMP-10 expression in PC3 cells.
To enlighten the molecular mechanisms responsi-
ble for the inhibitory effect of doxycycline on MMPs 
in LPS-induced PC3 human prostate cancer cells, we 
also assessed the contribution of NF-kB signaling to 
this effect. Interestingly, there are only a few studies 
regarding the effects of doxycycline on NF-kB-depen-
dent MMP gene regulation. In one of the previous 
studies doxycycline was shown to inhibit phosphoryla-
tion and nuclear translocation of the NF-kB-p65 and 
NF-kB-induced MMP-9 expression in lung cancer cell 
migration and invasion [41]. In another study in hu-
man dermal fibroblasts doxycycline inhibited TNF-a-
-induced NF-kB-mediated MMP-2 expression but not 
MMP-9 expression [46]. Consistently with the results 
of these studies, we observed that inhibition of MMP-9 
and -8 expression by doxycycline was associated with 
the down-regulation in the expression of NF-kB/p65, 
IKK-b and the reduction in the phosphorylation of 
IkB-a in PC3 prostate cancer cells. The inhibitory 
effect of doxycycline on IKK-b expression was also 
supported by our IHC findings. Thus, the present 
study provides original evidence that down-regulation 
of MMPs, in particular MMP-9 and -8, caused by 
doxycycline may be associated with the inhibition of 
NF-kB signaling pathway in LPS-induced PC3 cells.
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In conclusion, our results indicate that doxycycline 
inhibits the expression of various MMPs and NF-kB 
signaling may have a role in the regulation of the 
expression of MMPs in LPS-induced PC3 human 
prostate cancer cells. The results of the present study 
may help to clarify the cellular mechanisms of the in-
hibitory effect of doxycycline at subantimicrobial dose 
in LPS-induced PC3 cells and to encourage future 
use of doxycycline as an additional novel therapeutic 
agent in prostate cancer treatment.
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